{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:44:56Z","timestamp":1778885096061,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00108-018-0416-3","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T13:43:49Z","timestamp":1524059029000},"page":"861-867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cystinose","Cystinosis"],"prefix":"10.1007","volume":"59","author":[{"given":"Jessica","family":"Kaufeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Kurschat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Canaan-Kuehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Pape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"416_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00467-016-3438-x","volume":"32","author":"T Ahlenstiel-Grunow","year":"2017","unstructured":"Ahlenstiel-Grunow T, Kanzelmeyer NK, Froede K, Kreuzer M, Drube J, Lerch C, Pape L (2017) Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a\u00a0retrospective real-life single-center study. Pediatr Nephrol 32:91\u201397","journal-title":"Pediatr Nephrol"},{"key":"416_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ndt\/gfu329","volume":"30","author":"G Ariceta","year":"2015","unstructured":"Ariceta G, Lara E, Camacho JA, Oppenheimer F, Vara J, Santos F, Mu\u00f1oz MA, Cantarell C, Calvo GM, Romero R, Valenciano B, Garc\u00eda-Nieto V, Sanahuja MJ, Crespo J, Justa ML, Urisarri A, Bedoya R, Bueno A, Daza A, Bravo J, Llamas F, Jim\u00e9nez Del Cerro LA (2015) Cysteamine (Cystagon(R)) adherence in patients with cystinosis in Spain: successful in children and a\u00a0challenge in adolescents and adults. Nephrol Dial Transplant 30:475\u2013480","journal-title":"Nephrol Dial Transplant"},{"key":"416_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/WNN.0b013e31828b9f11","volume":"26","author":"AO Ballantyne","year":"2013","unstructured":"Ballantyne AO, Spilkin AM, Trauner DA (2013) Executive function in nephropathic cystinosis. Cogn Behav Neurol 26:14\u201322","journal-title":"Cogn Behav Neurol"},{"key":"416_CR4","first-page":"254","volume":"13","author":"AO Ballantyne","year":"2000","unstructured":"Ballantyne AO, Trauner DA (2000) Neurobehavioral consequences of a\u00a0genetic metabolic disorder: visual processing deficits in infantile nephropathic cystinosis. Neuropsychiatry Neuropsychol Behav Neurol 13:254\u2013263","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"416_CR5","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1056\/NEJMc1309480","volume":"3","author":"A Bertholet-Thomas","year":"2014","unstructured":"Bertholet-Thomas A, Bacchetta J, Tasic V, Cochat P (2014) Nephropathic cystinosis \u2013 a gap between developing and developed nations. N\u00a0Engl J Med 3:1366\u20131367","journal-title":"N Engl J Med"},{"key":"416_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10545-010-9182-7","volume":"33","author":"MT Besouw","year":"2010","unstructured":"Besouw MT, Hulstijn-Dirkmaat GM, van der Rijken RE, Cornelissen EA, van Dael CM, Vande Walle J, Lilien MR, Levtchenko EN (2010) Neurocognitive functioning in school-aged cystinosis patients. J\u00a0Inherit Metab Dis 33:787\u2013793","journal-title":"J Inherit Metab Dis"},{"key":"416_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ki.2011.301","volume":"81","author":"S Cherqui","year":"2012","unstructured":"Cherqui S (2012) Cysteamine therapy: a\u00a0treatment for cystinosis, not a\u00a0cure. Kidney Int 81:127\u2013129","journal-title":"Kidney Int"},{"key":"416_CR8","doi-asserted-by":"publisher","first-page":"iv87","DOI":"10.1093\/ndt\/gfu090","volume":"29","author":"F Emma","year":"2014","unstructured":"Emma F, Nesterova G, Langman C, Labb\u00e9 A, Cherqui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E, Dohil R, Trauner D, Antignac C, Cochat P, Kaskel F, Servais A, W\u00fchl E, Niaudet P, Van\u2019t Hoff W, Gahl W, Levtchenko E (2014) Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant 29:iv87\u2013iv94","journal-title":"Nephrol Dial Transplant"},{"key":"416_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMra020552","volume":"347","author":"WA Gahl","year":"2002","unstructured":"Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N\u00a0Engl J Med 347:111\u2013121","journal-title":"N Engl J Med"},{"key":"416_CR10","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1093\/emboj\/20.21.5940","volume":"20","author":"V Kalatzis","year":"2001","unstructured":"Kalatzis V, Cherqui S, Antignac C, Gasnier B (2001) Cystinosin, the protein defective in cystinosis, is a\u00a0H(+)-driven lysosomal cystine transporter. EMBO\u00a0J 20:5940\u20135949","journal-title":"EMBO J"},{"key":"416_CR11","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.kint.2016.01.033","volume":"89","author":"CB Langman","year":"2016","unstructured":"Langman CB, Barshop BA, Desch\u00eanes G, Emma F, Goodyer P, Lipkin G, Midgley JP, Ottolenghi C, Servais A, Soliman NA, Thoene JG, Levtchenko EN (2016) Conference Participants. Controversies and research agenda in nephropathic cystinosis: conclusions from a\u00a0\u201cKidney Disease: improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int 89:1192\u20131203","journal-title":"Kidney Int"},{"key":"416_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpeds.2014.05.013","volume":"165","author":"CB Langman","year":"2014","unstructured":"Langman CB, Greenbaum LA, Grimm P, Sarwal M, Niaudet P, Deschenes G, Cornelissen EA, Morin D, Cochat P, Elenberg E, Hanna C, Gaillard S, Bagger MJ, Rioux P (2014) Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate. J\u00a0Pediatr 165:528\u2013533.e1","journal-title":"J Pediatr"},{"key":"416_CR13","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.2215\/CJN.12321211","volume":"7","author":"CB Langman","year":"2012","unstructured":"Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Desch\u00eanes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P (2012) A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol 7:1112\u20131120","journal-title":"Clin J Am Soc Nephrol"},{"key":"416_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00467-005-2052-0","volume":"21","author":"EN Levtchenko","year":"2006","unstructured":"Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, Blom HJ (2006) Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis. Pediatr Nephrol 21:110\u2013113","journal-title":"Pediatr Nephrol"},{"key":"416_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJM199304223281604","volume":"328","author":"TC Markello","year":"1993","unstructured":"Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N\u00a0Engl J Med 328:1157\u20131162","journal-title":"N Engl J Med"},{"key":"416_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11560-017-0152-z","volume":"12","author":"L Pape","year":"2017","unstructured":"Pape L et al (2017) Cystinose. Nephrologe 12:223\u2013229. \n                    https:\/\/doi.org\/10.1007\/s11560-017-0152-z","journal-title":"Nephrologe"},{"key":"416_CR17","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2215\/CJN.02000311","volume":"6","author":"KJ Stralen Van","year":"2011","unstructured":"Van Stralen KJ, Emma F, Jager KJ, Verrina E, Schaefer F, Laube GF, Lewis MA, Levtchenko EN (2011) Improvement in the renal prognosis in nephropathic cystinosis. Clin J Am Soc Nephrol CJASN 6:2485\u20132491","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"416_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jpeds.2013.01.027","volume":"163","author":"L Viltz","year":"2013","unstructured":"Viltz L, Trauner DA (2013) Effect of age at treatment on cognitive performance in patients with cystinosis. J\u00a0Pediatr 163:489\u2013492","journal-title":"J Pediatr"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0416-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0416-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0416-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:25:58Z","timestamp":1555547158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0416-3"}},"subtitle":["Diagnostik, cystinentspeichernde Therapie und Transition","Diagnosis, cystine-depleting therapy, and transition"],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0416-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"18 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Kaufeld, C.\u00a0Kurschat, E.\u00a0Brand und L.T.\u00a0Weber haben Honorare von Chiesi erhalten. S.\u00a0Canaan-Kuehl hat Honorare von Amicus, Chiesi, Genzyme\/Sanofi und Shire erhalten. J.\u00a0Oh und L.\u00a0Pape haben Forschungsunterst\u00fctzung und Honorare von Chiesi und Orphan Europe erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}